Výsledky vyhledávání - "Gail S. Shapiro"

A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol

Autor: Giovanni Della Cioppa, Jim Xiang, Ümit Yegen, John Kottakis, Gail S. Shapiro

Publikováno v: Clinical Therapeutics. 24:2077-2087

Inhaled short-acting beta(2)-adrenoceptor agonists are the most commonly used treatment for the prevention of exercise-induced bronchoconstriction (EIB). Formoterol, a long-acting beta(2)-adrenoceptor agonist, has been demonstrated to provide protect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec85ec20c331b8c1e78c53adec4a2dca
https://doi.org/10.1016/s0149-2918(02)80098-4

Zobrazit plný text záznamu

Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma

Autor: Bruce P. Ekholm, Nancy M. Klinger, Gene L. Colice, Gail S. Shapiro

Publikováno v: The Journal of asthma : official journal of the Association for the Care of Asthma. 37(8)

This was an open-label, parallel group, randomized, age-stratified, multicenter study designed to compare the safety and efficacy of regular use of albuterol formulated in hydrofluoroalkane-134a (HFA albuterol) and albuterol formulated in chlorofluor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b228e8ac0bf0787ef6f93305528af981
https://pubmed.ncbi.nlm.nih.gov/11192231

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání